Vinit Mahajan, MD, PhD, is a professor, vitreoretinal surgeon, and scientist in the Department of Ophthalmology and director of the Molecular Surgery and Omics Laboratory at Stanford University.
Two leading retinal specialists break down MCO-010's 3-year efficacy and safety data, the significance of contralateral eye findings, and how this gene-agnostic optogenetic approach could fill a critical gap for patients with advanced inherited retinal degeneration who have limited treatment options.
Single-shot optogenetic injection restores light sensitivity in advanced retinitis pigmentosa, delivering sustained vision gains for years with strong safety, expanding hope beyond gene-specific therapy.
May 12th 2026
